[SLRX] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
04-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- -21.57%
YoY- -117.65%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 0 0 -1,840 0 571 1,269 1,479 -
PBT -4,718 -6,109 -4,105 -3,737 -3,074 -1,852 -1,768 92.73%
Tax -38 -14 -44 -10 -42 47 10 -
NP -4,718 -6,095 -4,105 -3,737 -3,074 -1,852 -1,768 92.73%
Tax Rate - - - - - - - -
Total Cost 4,718 6,095 2,265 3,737 3,646 3,121 3,246 28.40%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 0.00 0.00 223.06 0.00 -538.05 -145.95 -119.52 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -2.20 -3.29 -2.27 -2.09 -1.72 -1.52 -2.84 -15.69%
EPS Diluted -2.20 -3.29 -2.27 -2.09 -1.72 -1.52 -2.84 -15.69%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.